- Home
- SXC vs AQST Comparison
SXC vs AQST Comparison
Compare SXC & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SXC | AQST |
|---|---|---|
| Founded | 1960 | 2004 |
| Country | United States | United States |
| Employees | 848 | N/A |
| Industry | Steel/Iron Ore | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 657.6M | 504.0M |
| IPO Year | 2011 | 2007 |
Fundamental Metrics
Financial Performance| Metric | SXC | AQST |
|---|---|---|
| Price | $8.89 | $4.02 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | $9.00 | $9.00 |
| AVG Volume (30 Days) | 1.7M | ★ 1.7M |
| Earning Date | 04-30-2026 | 05-01-2026 |
| Dividend Yield | ★ 7.17% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,600,300,000.00 | $67,430,000.00 |
| Revenue This Year | N/A | $10.08 |
| Revenue Next Year | N/A | $49.60 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 10.30 | 0.77 |
| 52 Week Low | $5.52 | $2.68 |
| 52 Week High | $9.28 | $7.55 |
Technical Indicators
Market Signals| Indicator | SXC | AQST |
|---|---|---|
| Relative Strength Index (RSI) | 75.99 | 44.22 |
| Support Level | $7.70 | $4.00 |
| Resistance Level | N/A | $4.38 |
| Average True Range (ATR) | 0.34 | 0.20 |
| MACD | 0.13 | -0.03 |
| Stochastic Oscillator | 83.78 | 6.07 |
Price Performance
Historical ComparisonAbout SXC SunCoke Energy Inc.
SunCoke Energy Inc operates as an independent producer of coke in the Americas. Its coke is mainly used as a principal raw material in the blast furnace steelmaking process as well as in the foundry production of casted iron. The company operates through two segments: Domestic Coke and Industrial Services. It offers metallurgical and thermal coal. The company also provides handling and/or mixing services to steel, coke, electric utility, coal-producing, and other manufacturing-based customers. The majority of revenue is derived from the Domestic Coke segment.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.